HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kline, G. M. Articles by DiSesa, V. J. Search for Related Content PubMed PubMed Citation Articles by Kline, G. M. Articles by DiSesa, V. J.

The Annals of Thoracic Surgery, Vol 57, 72-74, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Development of tolerance to experimental cardiac allografts in utero

GM Kline, Z Shen, M Mohiuddin, V Ruggiero, S Rostami and VJ DiSesa
Department of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, Philadelphia.

"Actively acquired tolerance" to foreign cells was described in 1953 by Medawar and colleagues and formed the basis for subsequent efforts in organ transplantation. We have applied these historic principles of intrauterine immune manipulation in a vascularized cardiac allograft model. Allogeneic Lewis-Brown Norway (LBN) splenocytes (0 to 5 x 10(7) cells) were injected intraperitoneally into each fetus of a pregnant Lewis rat at day 14 to 16 of gestation, when T cells are "educated" to distinguish self from foreign. This manipulation causes fetal attrition inversely proportional to the number of cells injected. Heterotopic transplantation using an LBN heart was carried out in each surviving fetus at 6 to 8 weeks of age. Untreated Lewis rats rejected LBN hearts within 7.6 days. Rats receiving LBN splenocytes in utero demonstrated prolongation of graft survival proportional to the number of cells given. Surviving animals exposed to 5 x 10(7) allogeneic cells in utero (n = 4) had graft survivals of 24 to more than 150 days (mean, 88.0 days), significantly longer than control animals (6 to 10 days; mean, 7.6 days; p < 0.02). Significant prolongation of cardiac allograft survival and in some cases complete tolerance can be achieved by intrauterine exposure to allogeneic cells at a critical period of immunologic development. Because many serious cardiac defects amenable to treatment by cardiac transplantation can be detected by ultrasound early in gestation, treatment based on this strategy may become useful in pediatric heart transplantation.

This article has been cited by other articles:

				D. D. Yuh, K. L. Gandy, B. A. Reitz, G. Hoyt, and R. C. Robbins PERINATAL INDUCTION OF IMMUNOTOLERANCE TO CARDIAC AND PULMONARY ALLOGRAFTS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 64 - 75. [Abstract] [Full Text]

				Z. Shen, M. Mohiuddin, and V. J. DiSesa Fetal Inoculation With Donor Cells in Cardiac Xenotransplantation Ann. Thorac. Surg., November 1, 1996; 62(5): 1360 - 1363. [Abstract] [Full Text]